CHICAGO, Dec. 17, 2025 /PRNewswire/ — PharmaCann Inc. (“PharmaCann“), together with certain of its affiliates and subsidiaries (together, the “Company“), one ofCHICAGO, Dec. 17, 2025 /PRNewswire/ — PharmaCann Inc. (“PharmaCann“), together with certain of its affiliates and subsidiaries (together, the “Company“), one of

PharmaCann Inc. Announces Sale of Certain Colorado Assets to Vireo Growth Inc.

CHICAGO, Dec. 17, 2025 /PRNewswire/ — PharmaCann Inc. (“PharmaCann“), together with certain of its affiliates and subsidiaries (together, the “Company“), one of the country’s largest vertically integrated cannabis companies, announced today that it has entered into an agreement to sell certain of its retail assets in Colorado (the “Assets“) to Vireo Growth Inc. (“Vireo“) for total consideration of $49 million in the form of newly issued Vireo shares (the “Transaction“). Founded in 2014, Vireo is a pioneering medical and adult-use cannabis company. The Transaction increases Vireo’s presence in the Colorado cannabis market while allowing it to continue to serve the broader medical and adult-use cannabis markets with high-quality products.

The Transaction contemplates the Company selling the following Assets associated with its Colorado affiliates to Vireo: (i) certain leases for operational dispensaries located in Colorado; (ii) licenses, permits, and authorizations required for the sale of cannabis products in the State of Colorado (subject to regulatory review and approvals); and (iii) certain of the Company’s inventory, contracts, and intellectual property, including certain marks associated with the LivWell brand.

Completion of the Transaction is subject to certain conditions, including state and local regulatory approval. The Company has also executed a management services agreement (the “MSA”) with Vireo pursuant to which, after regulatory approval of such MSA, Vireo will participate in the operations of certain of the Company’s dispensaries in Colorado until the closing of the proposed Transaction, among other things.

About PharmaCann. PharmaCann is one of the largest privately held, vertically integrated cannabis companies in the United States, with active operations in over half a dozen states. Through its portfolio of premium cannabis brands, PharmaCann delivers high-quality products to both medical and adult-use cannabis markets.

Cision View original content:https://www.prnewswire.com/news-releases/pharmacann-inc-announces-sale-of-certain-colorado-assets-to-vireo-growth-inc-302644686.html

SOURCE PharmaCann

Market Opportunity
WorldAssets Logo
WorldAssets Price(INC)
$0.5802
$0.5802$0.5802
+0.32%
USD
WorldAssets (INC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Woodway Assurance receives $1 million in funding for data privacy assurance solution EviData

Woodway Assurance receives $1 million in funding for data privacy assurance solution EviData

OTTAWA, ON, Dec. 17, 2025 /PRNewswire/ – New Canadian technology company Woodway Assurance is proud to announce that it has closed an oversubscribed seed funding
Share
AI Journal2025/12/17 23:16
Wormhole Unleashes W 2.0 Tokenomics for a Connected Blockchain Future

Wormhole Unleashes W 2.0 Tokenomics for a Connected Blockchain Future

TLDR Wormhole reinvents W Tokenomics with Reserve, yield, and unlock upgrades. W Tokenomics: 4% yield, bi-weekly unlocks, and a sustainable Reserve Wormhole shifts to long-term value with treasury, yield, and smoother unlocks. Stakers earn 4% base yield as Wormhole optimizes unlocks for stability. Wormhole’s new Tokenomics align growth, yield, and stability for W holders. Wormhole [...] The post Wormhole Unleashes W 2.0 Tokenomics for a Connected Blockchain Future appeared first on CoinCentral.
Share
Coincentral2025/09/18 02:07
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Share
BitcoinEthereumNews2025/09/18 01:44